| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10968830 | Vaccine | 2011 | 10 Pages |
Abstract
To optimize response rates in future vaccination campaigns, health authorities should provide more information on vaccine benefits and possible risks, tailoring this information to specific risk groups. Health authorities should also invest in the development and implementation of effective vaccine risk/benefit communication tools.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Marloes Bults, Desirée J.M.A. Beaujean, Jan Hendrik Richardus, Jim E. van Steenbergen, Hélène A.C.M. Voeten,